Laura Melado Vidales: High-Specific AMH Assays Refine Assessment of Low Ovarian Reserve
Laura Melado Vidales, Medical Director ART Fertility Clinics Abu Dhabi at ART Fertility Clinics, shared a post on LinkedIn about a paper published in Frontiers:
“Excited to share that our new paper is out in Frontiers in Endocrinology!
‘How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-Müllerian hormone with antral follicle count.’
Read here.
We show that combining high-specific AMH assays with antral follicle count (AFC) improves the prediction of ovarian response in women with low ovarian reserve, supporting more personalized fertility care.
Grateful to my co-authors and colleagues for this great collaboration!”
Title: How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count
Authors: Laura Melado, Ajay Kumar, Bhanu Kalra, Erkan Kalafat, Barbara Lawrenz, Human Fatemi

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 7, 2026, 16:23Amelia Degenkolb: ACOG 2026 Brings Innovation, Partnership and Patient Access Into Focus
-
May 7, 2026, 16:15New FIGO-IPPS Classification for Female Chronic Pelvic Pain – IJGO
-
May 7, 2026, 16:05Marco Zaccaria: How Uterine Fibroids Affect Latina Women
-
May 7, 2026, 12:36Adela Serban: Advanced Imaging Technique Enhances Uterine Imaging with 3D Ultrasound and Uterine Tracing
-
May 7, 2026, 12:26David Sable Highlights The Quest for Fertility as a Deep and Valuable Read
-
May 7, 2026, 12:20May Is Preeclampsia Awareness Month – The Society for Maternal-Fetal Medicine
-
May 7, 2026, 12:15PCOS Symptoms Should Not Be Dismissed – PCOS Awareness Association
-
May 7, 2026, 12:08Marco Zaccaria: The Role of the Junctional Zone in the Management of Adenomyosis With Infertility
-
May 7, 2026, 12:04Emad Sedeek: Understanding the Differences in PGT-A, PGT-M and PGT-P Embryogenetic Testing
